Dr. Bagheri PhD holds a PhD in Molecular Genetics and completed postdoctoral training in Cancer Biology.
He has more than 15 years of academic and research experience, along with over 3 years of experience in establishing and leading pharmaceutical and biotechnology initiatives in the United States.
expertise focuses on identifying disease mechanisms, discovering novel therapeutic targets, and developing innovative treatment strategies and drugs, particularly in the field of cancer. His research integrates molecular biology, genetics, advanced multi-omics technologies, and precision medicine to better understand disease progression and therapeutic response.